In non-small cell lung carcinoma (NSCLC), low levels of highly differentiated CD4+ T cells were associated with innate resistance and hyper-progression to immunotherapy [31], however in contrast, Russo et al. did not observe any correlation between hyper-progression and levels of CD4+/CD8+ TILs [32]. This evidence concerns the gene CD4 and non-small cell lung carcinoma.